Reducing Pseudomonas sputum density in bronchiectasis

Affiliations

Free article

Editorial

Oriol Sibila. Eur Respir J. 2021.

Free article

. 2021 Jan 5;57(1):2003390.

doi: 10.1183/13993003.03390-2020. Print 2021 Jan.

¹ Respiratory Dept, Hospital Clinic, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain osibila@clinic.cat.

No abstract available

Conflict of interest statement

Conflict of interest: O. Sibila has nothing to disclose.

Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.
Loebinger MR, Polverino E, Chalmers JD, Tiddens HAWM, Goossens H, Tunney M, Ringshausen FC, Hill AT, Pathan R, Angyalosi G, Blasi F, Elborn SJ, Haworth CS; iBEST-1 Trial Team. Loebinger MR, et al. Eur Respir J. 2021 Jan 5;57(1):2001451. doi: 10.1183/13993003.01451-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32855225 Clinical Trial.